Keyphrases
Anterior Thalamus
100%
Deep Brain Stimulation
100%
Tumor
68%
Glioma
61%
Poor Outcome
56%
Refractory Epilepsy
52%
Differential Mobility Spectrometry
50%
Diffuse Glioma
47%
Glioblastoma
38%
Isocitrate Dehydrogenase 1 (IDH1)
30%
Stimulation Targets
29%
Spectrometry Analysis
29%
IDH-mutant Astrocytoma
28%
Stem Cells
28%
Thalamic
26%
University Hospital
26%
Immediate Effect
25%
Single-center Study
25%
Fibroblast Growth Factor Receptor 3 (FGFR3)
25%
Physiological Function
25%
Attention-emotion Interaction
25%
Treatment Setting
25%
Impedance Characteristics
25%
Zinc Finger E-box Binding Homeobox 1 (ZEB1)
25%
Astrocytic Glioma
25%
Timing of Surgery
25%
Wearable Sensors
25%
Physiological Condition
25%
Executive Function
25%
Atypical Teratoid Rhabdoid Tumor (AT/RT)
25%
Biofluids
25%
Condition Monitoring
25%
CNTNAP2
25%
PTPRD
25%
Oligodendroglioma
25%
Genomic Characterization
25%
Aberrant DNA Methylation
25%
Seizure Outcome
25%
Surgery Treatment
25%
Isocitrate Dehydrogenase mutation
25%
Intraoperative Microelectrode Recordings
25%
Intraoperative Detection
25%
3T MRI
25%
Main Symptoms
25%
Adjuvant Therapy
25%
Motor Dysfunction
25%
Developmental Trajectories
25%
Tumor Aggressiveness
25%
Activity Monitoring
25%
High Angular Resolution
25%
Neuroscience
Deep Brain Stimulation
100%
Thalamus
79%
Intractable Epilepsy
54%
Isocitrate Dehydrogenase
50%
Astrocytoma
44%
Medulloblastoma
33%
Stem Cell
33%
Stereotypic Movement Disorder
30%
Intracranial Tumor
28%
Staining Technique
25%
Epithelial Mesenchymal Transition
25%
Magnetic Resonance Imaging
25%
DNA Repair
25%
DNA Methylation
25%
Oligodendroglioma
25%
Angular Resolution
25%
Tractography
25%
Diffusion MRI
25%
Lip
25%
Executive Function
25%
Fibroblast Growth Factor Receptor 3
25%
Cognitive Disorders
18%
Epileptic Seizure
18%
Temozolomide
16%
In Vivo
14%
Epidermal Growth Factor Receptor
14%
Headache
12%
Paresis
12%
P53
12%
Hypoxia-Inducible Factors
12%
Neural Cell Adhesion Molecule
12%
Low-Grade Glioma
12%
Deconvolution
10%
Gene Mutation
8%
Cell Cycle
8%
DNA Methyltransferase 3A
8%
Cohort Analysis
8%
Cell Cycle Checkpoint
8%
Growth Factor
8%
MSH2
8%
Radiation Therapy
8%
Magnetic Resonance Imaging
7%
Gene Expression
7%
Fibroblast Growth Factor Receptor
7%
Speech Disorder
6%
Meningioma
6%
Pilocytic Astrocytoma
6%
Neurosurgery
6%
Occipital Lobe
5%
Amygdala
5%
Medicine and Dentistry
Ganglioglioma
73%
Neoplasm
62%
Thalamus
50%
Deep Brain Stimulation
50%
Epileptic Seizure
43%
Glioblastoma
39%
Oligoastrocytoma
31%
Stereotypic Movement Disorder
30%
Adjuvant Therapy
27%
Intractable Epilepsy
25%
Drug Resistant Epilepsy
25%
Oligodendroglioma
25%
Patient Referral
25%
Fibroblast Growth Factor Receptor 3
25%
Diffusion MRI
25%
Tractography
25%
Medulloblastoma
25%
Smoke
25%
Diathermy
25%
Intracranial Tumor
25%
Spectroscopy
25%
Stem Cell
25%
Isocitrate Dehydrogenase
25%
Tumor Immune Microenvironment
25%
Isocitric Acid
18%
Hazard Ratio
18%
Cognitive Defect
18%
DNA Repair
12%
Dizziness
12%
Paresis
12%
Headache
12%
Cerebrospinal Fluid
11%
Multivariate Analysis
10%
Radiation Therapy
10%
Volunteer
10%
Ex Vivo
10%
Neurosurgery
10%
Temozolomide
8%
Magnetic Resonance Imaging
7%
Fibroblast Growth Factor Receptor
7%
Endothelial Cell
7%
Overall Survival
6%
The Cancer Genome Atlas
6%
Proportional Hazards Model
6%
Electronic Patient Record
6%
Long Term Survival
6%
Median Survival Time
6%
Tumor Bleeding
6%
Speech Disorder
6%
Prognostic Factor
6%
